Tue, Feb 06, 2018
Lupin's consolidated PAT more than halved in Q3FY18 to Rs 221.7 crore, down by 65% from Rs 633.1 crore, in the corresponding period of the previous year.
More >
Thu, Feb 09, 2017
Pharmaceutical-major Lupin on Thursday reported 21% rise in net profit during the quarter ended on December 31.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.